Short- and Long-Term Performance of Mechanical Versus Biological Prostheses for Aortic Valve Replacement in Patients with Severe Symptomatic Aortic Stenosis over 65 Years
Author(s)
Pérez D1, Maroto L1, Cobiella J1, Montero L1, Torres B1, Carnero M1, Marti Sanchez B2, Diaz A3, Cuervo J4
1Hospital Universitario Clínico San Carlos, Madrid, Spain, 2Edwards Lifesciences, MADRID, M, Spain, 3Axentiva Solutions, Barcelona, Spain, 4Axentiva Solutions, Oviedo, TF, Spain
OBJECTIVES : Latest clinical guidelines recommend biological prostheses as a reasonable choice in patients ≥65 years requiring aortic valve replacement (AVR). The aim is to compare clinical outcomes (major adverse events survival at short and long term) and resource-consumption (health resources, anticoagulation rates and post-surgery length of stay in ward -LoS- and intensive care unit -ICU-) between mechanical (MAVI) and biological aortic valve implants (BAVI) in AVR. METHODS : An observational, retrospective study including all consecutive patients undergoing AVR with an isolated BAVI or MAVI between 2003 and 2016. Patients were followed-up until June 30th, 2020. In this analysis, patients >65y were considered (n=1,055: 881 BAVI, 174 MAVI). Propensity score matching and multivariate competing risks models with HR correction were applied to estimate differences in the clinical outcomes. Besides, non-parametric tests and multivariate count models were conducted to evaluate differences in resource-consumption. RESULTS : At short term, low complication rates in both types of implants were observed among the matched sample. At long term, no differences in all-cause mortality were found (HR=0.848; CI: 0.663—1.086; p>0.1). Furthermore, BAVIs were associated to a lower prevalence of postoperative anticoagulant treatment (31.6% vs. 82.8%; p<0.01). Regarding ICU, BAVI were found to have a 51% shorter stay until discharge (p<0.01) than patients with MAVI. Analyses by time periods showed a downward trend in ward and ICU stays. During follow-up, other healthcare resources (i.e., number of echocardiograms, visits to cardiologist) were higher among BAVI. CONCLUSIONS : Low perioperative rates of complications in both MAVI and BAVI were found, and long-term survival was similar in patients over 65y of age. BAVI was associated with a shorter post-surgery ICU stay and lower rates of anticoagulants, which might be related to recent advancements in biological implant technology and should be incorporated in further economic analyses.
Conference/Value in Health Info
2021-11, ISPOR Europe 2021, Copenhagen, Denmark
Value in Health, Volume 24, Issue 12, S2 (December 2021)
Code
POSB9
Topic
Clinical Outcomes
Topic Subcategory
Performance-based Outcomes
Disease
Cardiovascular Disorders